. Author manuscript; available in PMC: 2014 Aug 21.

Published in final edited form as: J Biol Chem. 2006 Apr 19;281(29):19872–19880. doi: 10.1074/jbc.M509058200

TABLE 3. Percentage of MLN cells expressing surface antigenic markers in each group.

Data are means ± S.D. (% (gated)), n = 4. CS was administered orally ad libitum from 7 days before the first immunization to 7 days after the second immunization. The control group had ad libitum free access to water.

	CD3⁺CD45R/B220⁻, T cell	CD3⁻CD45R/B220⁺, B cell	CD4⁺CD8⁻, CD4	CD4⁻CD8⁺, CD8	CD4⁺CD25⁺
CS	72.0 ± 2.3	26.4 ± 2.2	55.6 ± 4.1	14.9 ± 0.2	6.6 ± 0.1^a
Control	70.2 ± 1.0	28.4 ± 1.1	53.3 ± 1.7	14.0 ± 0.6	6.1 ± 0.4

Significantly different from control at p < 0.05.